Single chain variable fragment CD7 antibody conjugated PLGA/HDAC inhibitor immuno-nanoparticles: developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV

MeSH terms

• Anti-HIV Agents / chemistry
• Anti-HIV Agents / metabolism
• Anti-HIV Agents / pharmacology*
• Anti-HIV Agents / toxicity
• Antigens, CD7 / immunology*
• Cell Line
• Chemistry, Pharmaceutical
• Chromatography, High Pressure Liquid
• Delayed-Action Preparations
• Drug Carriers*
• Drug Compounding
• Flow Cytometry
• HIV / drug effects*
• HIV / physiology
• Histone Deacetylase Inhibitors / chemistry
• Histone Deacetylase Inhibitors / metabolism
• Histone Deacetylase Inhibitors / pharmacology*
• Histone Deacetylase Inhibitors / toxicity
• Humans
• Immunoconjugates / chemistry
• Immunoconjugates / metabolism
• Immunoconjugates / pharmacology*
• Immunoconjugates / toxicity
• Lactic Acid / chemistry*
• Microscopy, Electron, Scanning
• Nanoparticles*
• Nanotechnology
• Particle Size
• Polyglycolic Acid / chemistry*
• Polylactic Acid-Polyglycolic Acid Copolymer
• Single-Chain Antibodies / chemistry
• Single-Chain Antibodies / metabolism*
• T-Lymphocytes / immunology
• T-Lymphocytes / metabolism*
• T-Lymphocytes / virology
• Technology, Pharmaceutical / methods
• Virus Latency